Latest filing published 02 Mar 2012 for GenMark Diagnostics, Inc..
Insider track record
No signal scores available.
Matthew Robert Cohen: trading record in brief
All filings by Matthew Robert Cohen on record concern GenMark Diagnostics, Inc. In total, 2 filings cover trades dated from 3 January 2012 to 29 February 2012.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 2 March 2012: a share grant, in GenMark Diagnostics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Robert Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares0Common StockSEC:0001181431-12-013957:0
- 26,856 shares@ US$4.38Common StockSEC:0001181431-12-001576:0
2 of 2 declarations
